Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) on Mar. 31 released the top line results of the 12-month Phase II Imaging trial in Alzheimer’s Disease (“IMAGINE” Trial), based on draft results. Prana’s PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer’s disease patients, as measured using PiB-PET Standardized Uptake Value Ratio (SUVR). Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) shares after opening at $270 moved to $2.71 on last trade day and at the end of the day closed at $2.30. Company price to sales ratio in past twelve months was calculated as 321.62 and price to cash ratio as 5.51.Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) showed a negative weekly performance of -79.34%.
Ventrus Biosciences Inc (NASDAQ:VTUS)’s shares jumped 2.94% to $1.40. The company on Feb. 12 announced top line efficacy and safety results from the second Phase 3 clinical trial of Diltiazem Hydrochloride 2% Cream (VEN 307) in patients with pain related to anal fissure (AF). In this randomized double blind trial comparing diltiazem 2% cream versus placebo cream in 434 subjects in 90 centers globally, both treatment arms demonstrated a clinically meaningful improvement. Ventrus Biosciences Inc (NASDAQ:VTUS) shares -6.67% in last trading session and ended the day on $1.19. VTUS return on equity ratio is recorded as -60.40% and its return on assets is -55.60%.Ventrus Biosciences Inc (NASDAQ:VTUS) yearly performance is -55.93%.
New Lead Holdings Ltd (NASDAQ:NEWL) witnessed its shares falling 1.05 percent to $1.89 during Tuesday trading. The shares which started trading at $1.89 ended up shifting hands between $1.81 and $2.18 during the day on above average volume of shares. The $1.67 million market capped bulk shipping company has witnessed its stock falling from grace to grass in the past year. That from the 52-week high of $297, the shares are wallowing at the bottom at $1.89. But all this has been because of the trouble that bulk shipping companies have known since 2013 where contracts and shipping rates have declined. New Lead Holdings Ltd (NASDAQ:NEWL) shares moved down -13.75% in last trading session and was closed at $1.38, while trading in range of $1.36 – 1.65. New Lead Holdings Ltd (NASDAQ:NEWL) year to date (YTD) performance -92.90%.
Many investors appear to be quite bearish on Onconova Therapeutics Inc. (NASDAQ:ONTX), especially if you look at the percentage of the float that is sold short for this stock. Currently, 20.3% of the float is sold short, suggesting an extreme level of bearishness for ONTX. Onconova Therapeutics Inc (NASDAQ:ONTX) weekly performance is -8.27%. On last trading day company shares ended up $6.21. Onconova Therapeutics Inc (NASDAQ:ONTX) distance from 50-day simple moving average (SMA50) is -40.46%. Analysts mean target price for the company is $11.50.
Leave a Reply